ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 90 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.99 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $724,796 | +236.4% | 228,642 | +427.5% | 0.00% | – |
| Q2 2023 | $215,431 | -90.0% | 43,346 | -90.0% | 0.00% | -100.0% |
| Q1 2023 | $2,149,000 | +1480.1% | 435,020 | +3354.5% | 0.01% | – |
| Q3 2022 | $136,000 | -99.0% | 12,593 | -98.7% | 0.00% | -100.0% |
| Q4 2021 | $14,153,000 | +18.9% | 948,624 | +107.8% | 0.03% | -51.9% |
| Q2 2021 | $11,908,000 | +364.1% | 456,591 | +245.9% | 0.05% | +107.7% |
| Q1 2020 | $2,566,000 | -35.5% | 132,006 | -13.8% | 0.03% | -3.7% |
| Q4 2019 | $3,977,000 | +657.5% | 153,105 | +684.2% | 0.03% | +575.0% |
| Q2 2019 | $525,000 | -85.3% | 19,524 | -84.2% | 0.00% | -76.5% |
| Q1 2019 | $3,564,000 | – | 123,284 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $5,700,177 | 8.82% |
| Wildcat Capital Management, LLC | 1,920,787 | $6,088,895 | 2.44% |
| TPG GP A, LLC | 18,716,306 | $59,330,690 | 1.02% |
| EcoR1 Capital, LLC | 4,488,200 | $14,227,594 | 0.48% |
| CROSSPOINT FINANCIAL, LLC | 12,000 | $38,040 | 0.40% |
| Coastal Bridge Advisors, LLC | 406,847 | $1,289,705 | 0.35% |
| CAXTON ASSOCIATES LP | 480,104 | $1,521,930 | 0.21% |
| Woodline Partners LP | 5,313,915 | $16,845,111 | 0.20% |
| Rhenman & Partners Asset Management AB | 300,000 | $951,000 | 0.10% |
| Navalign, LLC | 75,365 | $238,907 | 0.09% |